Description
Tranexamic Acid Tablets (Hemostat)
Healthy Inc is a premier global supplier and exporter of hemostatic agents. We provide high-quality Tranexamic Acid Tablets, manufactured in our WHO–GMP certified facilities. This potent anti-fibrinolytic drug is a top export to pharmacy chains and hospitals in Africa, LATAM, Southeast Asia, and the Middle East for the effective management of heavy bleeding (menorrhagia) and surgical hemorrhage.
Product Overview
Tranexamic Acid is a synthetic derivative of the amino acid lysine. It acts as an Anti-fibrinolytic Agent by competitively inhibiting the activation of plasminogen to plasmin, thereby preventing the breakdown of blood clots.
It is the “Standard of Care” for:
- Menorrhagia: Significantly reduces blood loss in women with cyclic heavy menstrual bleeding.
- Trauma & Surgery: Minimizes perioperative blood loss in orthopedic and cardiac surgeries.
- Dermatology (Off-Label): Widely used for the treatment of Melasma and hyperpigmentation disorders.
- Dental Procedures: Prevention of hemorrhage in patients with hemophilia undergoing tooth extraction.
Product Composition & Strength
We supply this product in film-coated tablets for oral administration.
| Active Ingredient | Strength | Form |
|---|---|---|
| Tranexamic Acid BP/USP | 250 mg | Film Coated Tablet |
| Tranexamic Acid BP/USP | 500 mg | Film Coated Tablet |
*Available in Alu-Alu or PVC/Alu Blister Packs.
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers and Distributors.
| HS Code | 3004.90.99 (Medicaments for therapeutic uses) |
| Dosage Form | Solid Oral Dosage (Tablet) |
| Packaging | 10×10 Blister Pack / 10x1x10 Mono Carton |
| Storage | Store below 30°C. Protect from moisture. |
| Certificates | WHO-GMP, COPP, FSC, CTD Dossier |
Manufacturing Authority
Manufactured at our WHO-GMP & ISO 9001:2015 certified unit.
- Coating: Advanced film-coating technology ensures tablets are easy to swallow and tasteless.
- Dissolution: Optimized dissolution profile for reliable bioavailability.
- Capacity: High-speed tableting lines capable of fulfilling large commercial orders.
Therapeutic Indications
Indicated for the treatment of:
- Gynecology: Cyclic heavy menstrual bleeding (Menorrhagia).
- Surgery: Prophylaxis and treatment of hemorrhage in general surgery, urology (prostatectomy), and gynecology.
- Hereditary Angioedema: Short-term prevention of edema attacks.
- Epistaxis: Severe nosebleeds.
Dosage & Administration
Strict Medical Supervision Required:
- Menorrhagia: 1000 mg (2 x 500mg tablets) three times daily for up to 4 days during menstruation.
- Surgery/Trauma: 1000 mg to 1500 mg, 2 to 3 times daily.
- Melasma (Dermatologist Prescribed): Typically lower doses (e.g., 250 mg twice daily) for extended periods.
Safety Warnings:
- Thrombosis: Contraindicated in patients with active thromboembolic disease (Deep Vein Thrombosis, Pulmonary Embolism).
- Renal Impairment: Dose reduction is mandatory in patients with kidney disease.
Commercial Inquiries
For hospital tenders, bulk export, or distributor pricing, please contact our export team.
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in
